超声造影剂到达时间差比值鉴别良性与恶性胸膜下肺病变
这项前瞻性研究纳入902例胸膜下肺病变患者,分为开发队列424例和验证队列478例,从5项超声造影指标中筛选出到达时间差比值作为最优指标。验证队列中该指标在全体、大病变(垂直径>3 cm)和小病变(垂直径≤3 cm)的界值分别为43%、42%和50%,AUC分别为0.91、0.97和0.77,均高于现有超声造影诊断标准。
要点
- 到达时间差比值鉴别良恶性胸膜下肺病变优于现有超声造影指标。
- 垂直径>3 cm病变诊断效能最高,验证队列AUC达0.97。
- 垂直径≤3 cm小病变诊断效能相对较低,验证队列AUC为0.77。
核心结论
- 超声造影剂到达时间差比值较现有诊断标准能更好地鉴别良性与恶性胸膜下肺病变。
研究设计与样本
- 前瞻性研究(中国临床试验注册号ChiCTR1800019828),2019年5月至2020年8月纳入胸膜下肺病变患者,分开发队列424例和验证队列478例,以病理分析、微生物学证据和临床随访为参考标准。
关键影像表现/征象
- 从5项超声造影指标中筛选出到达时间差比值为最优鉴别指标。
- 全体病变中到达时间差比值界值为43%,验证队列AUC为0.91(95% CI:0.88,0.93)。
- 大病变(垂直径>3 cm)中界值为42%,验证队列AUC为0.97(95% CI:0.94,0.98)。
- 小病变(垂直径≤3 cm)中界值为50%,验证队列AUC为0.77(95% CI:0.71,0.83)。
诊断标准与关键数值
- 全体病变验证队列到达时间差比值AUC 0.91,高于病变-肺到达时间差>2.5秒的0.81(P < .001)、病变到达时间>7.5秒的0.65(P < .001)和病变到达时间>10秒的0.67(P < .001)。
- 大病变验证队列到达时间差比值AUC 0.97,高于病变-肺到达时间差>2.5秒的0.85(P < .001)、病变到达时间>7.5秒的0.64(P < .001)和病变到达时间>10秒的0.68(P < .001)。
- 小病变验证队列到达时间差比值AUC 0.77,高于病变-肺到达时间差>2.5秒的0.7(P = .005)、病变到达时间>7.5秒的0.63(P < .001)和病变到达时间>10秒的0.64(P < .001)。
临床应用与阅片要点
- 对胸膜下肺病变行超声造影时,可测量并计算到达时间差比值,按病变大小选用相应界值(全体43%、大病变42%、小病变50%)辅助鉴别良恶性。
- 垂直径>3 cm病变中该指标诊断效能较高,垂直径≤3 cm小病变中诊断效能相对较低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background US has proven valuable in the diagnosis of subpleural pulmonary lesions (SPLs); however, existing US indicators have limitations. Purpose To propose and validate a revised contrast-enhanced (CE) US indicator for differential diagnosis of benign and malignant SPLs and to compare its performance with existing CE US diagnostic criteria. Materials and Methods This prospective study (Chinese clinical trial registry, ChiCTR1800019828) enrolled patients with SPLs between May 2019 and August 2020. They were divided into a developmental cohort (DC) and a validation cohort (VC). In the DC, the optimal indicator was selected from five CE US indicators. In the VC, the selected indicator was compared with existing CE US diagnostic criteria using the area under the receiver operating characteristic curve (AUC). Pathologic analysis, microbial evidence, and clinical follow-up were used as reference standards for all SPLs. Results A total of 902 participants (DC, 424 participants; VC, 478 participants) with SPLs (mean age, 56 years ± 17; 593 men) were evaluated. The arrival time (AT) difference ratio proved to be the optimal indicator to distinguish benign from malignant SPLs. In the overall (regardless of lesion size), large (vertical diameter >3 cm), and small (vertical diameter ≤3 cm) lesion groups, the cutoff values of the AT difference ratio were 43%, 42%, and 50% and the AUCs obtained from the VC were 0.91 (95% CI: 0.88, 0.93), 0.97 (95% CI: 0.94, 0.98), and 0.77 (95% CI: 0.71, 0.83) respectively, which were higher than those of lesion-lung AT difference greater than 2.5 seconds (0.81 [P < .001], 0.85 [P < .001], and 0.7 [P = .005], respectively), lesion AT greater than 7.5 seconds (0.65 [P < .001], 0.64 [P < .001], and 0.63 [P < .001], respectively), and lesion AT greater than 10 seconds (0.67 [P < .001], 0.68 [P < .001], and 0.64 [P < .001] respectively). Conclusion The US contrast agent arrival time difference ratio enables better differentiation of benign and malignant subpleural lesions when compared with existing diagnostic criteria. Online supplemental material is available for this article. Published under a CC BY 4.0 license.
引用
- Bi K, Zhou RR, Zhang Y, et al. US Contrast Agent Arrival Time Difference Ratio for Benign versus Malignant Subpleural Pulmonary Lesions. Radiology. 2021. PMID: 34282968. doi:10.1148/radiol.2021204642
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。